ipIQ

ipIQ, formerly known as The Patent Board, was a leading provider of patent-based intellectual property (IP) analytics and consulting services, with a significant focus on the life sciences and healthcare sectors. The company specialized in quantifying the value and impact of corporate innovation by tracking patent citations, technology strength, and R&D productivity. Its proprietary metrics, such as the Science Strength and Technology Strength indicators, were widely used by pharmaceutical and biotech firms to benchmark their intellectual property portfolios against competitors. Through its legacy as CHI Research, ipIQ provided deep insights into the link between scientific research and commercial technology, helping healthcare organizations optimize their innovation strategies.